Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
VCYT vs GRAL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
GRAL Captures Overall Composite Edge (54.5 HOLD vs 49.1 HOLD), While VCYT Leads 5–1 on Growth & Valuation Pillars
GRAL Overall Winner
6-Pillar Tally: VCYT 5 – 1 GRAL
Matrix Metrics: VCYT 4 – 6 GRAL
As of Nov 16, 2026, GRAIL, Inc. (GRAL) captures the overall head-to-head institutional edge over Veracyte, Inc. (VCYT) on higher Unified Composite conviction (54.5/100 HOLD vs. 49.1/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples), while VCYT wins 5–1 across the 6-pillar growth and valuation breakdown. VCYT trades at $24.01 (15.3x Forward P/E, 15.0% operating margin) versus GRAL at $105.60 (1.1x Forward P/E, -332.0% operating margin).
- Growth vs. Quality Trade-Off: GRAL earns the overall head-to-head edge with a stronger Unified Composite Score (54.5/100 HOLD vs. VCYT 49.1/100 HOLD) and 3.09β · 99% Vol risk profile, whereas VCYT leads top-line expansion (+15.1% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
- Technical & Structure Timing Caution: VCYT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 27.8); meanwhile GRAL is in a Breakdown options structure phase (RSI 37.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About VCYT vs GRAL
VCYT
Veracyte, Inc.
$24.01
-1.32% 1D
Market Cap
$2.0B
TTM Revenue
$582M
Forward P/E
15.3x
Beta / 30D Vol
3.01β · 199% Vol
Unified Composite Score
49.1
HOLD
Tech 55.0
Fund 56.0
Flow 57.0
Mom 55.0
Weinstein Technical Phase
Markdown · Sell / avoid
GRAL
Head-to-Head Winner
GRAIL, Inc. Common Stock
$105.60
-8.88% 1D
Market Cap
$5.2B
TTM Revenue
$167M
Forward P/E
1.1x
Beta / 30D Vol
3.09β · 99% Vol
Unified Composite Score
54.5
HOLD
Tech 35.0
Fund 49.0
Flow 57.0
Mom 60.0
Weinstein Technical Phase
Neutral · Hold
6-Pillar Scorecard Institutional Category Breakdown (VCYT 5 – 1 GRAL)
1. Valuation Multiples
GRAL
Forward P/E
15.3x
1.1x
Trailing P/E
15.8x
1.1x
PEG Ratio
N/M
N/M
EV / Revenue
3.1x
31.6x
2. Growth & Scale
VCYT
Revenue Growth (YoY)
+15.1%
+3.7%
Earnings Growth (YoY)
+58.3%
+0.0%
TTM Revenue (USD)
$582M
$167M
Market Cap
$2.0B
$5.2B
3. Profitability & Quality
VCYT
Gross Margin
74.2%
46.7%
Operating Margin
15.0%
-332.0%
Net Profit Margin
21.8%
-243.8%
Return on Equity (ROE)
9.4%
-17.3%
4. Balance Sheet & Cash Flow
VCYT
Cash Generation (TTM)
$162M
-$312M
Cash Flow Margin
27.8%
N/A
Net Cash / Leverage
$159M Net Cash
$57M Net Debt (0.03x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
VCYT
Options Structure Phase
BREAKDOWN
BREAKDOWN
Current IV / %ile
197.3% (47th %ile)
93.0% (53rd %ile)
Put/Call OI Skew
0.01x (Call-Skewed)
0.81x (Call-Skewed)
OBV Trend / Tech Phase
DISTRIBUTION · Markdown
DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat
VCYT
OpEx & R&D Intensity
59.2% of Rev ($344M)
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Scale & Operating Efficiency Moat
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Diagnostics & Research Operator
Diagnostics & Research Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: VCYT (4) vs GRAL (6)| Institutional Metric | VCYT | GRAL | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $2.0B | $5.2B | GRAL | |
| Trailing P/E Ratio | 15.8x | 1.1x | GRAL | |
| Forward P/E Ratio | 15.3x | 1.1x | GRAL | |
| Revenue Growth (YoY) | +15.1% | +3.7% | VCYT | |
| Operating Margin (TTM) | 15.0% | -332.0% | VCYT | |
| Net Profit Margin | 21.8% | -243.8% | VCYT | |
| Return on Equity (ROE) | 9.4% | -17.3% | VCYT | |
| 52-Week Range Position | 5% ($22–$61) | 51% ($42–$166) | GRAL | |
| Beta / 30D Volatility | 3.01β · 199% Vol | 3.09β · 99% Vol | GRAL | |
| Unified Institutional Score | 49.1 / 100 (HOLD) | 54.5 / 100 (HOLD) | GRAL | |
| Trailing 12M Revenue (USD) | $582M | $167M | Scale | |
| Gross Profit Margin (TTM) | 74.2% | 46.7% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 3.1x EV/Rev | N/M PEG · 31.6x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $162M ($159M Net Cash) | -$312M ($57M Net Debt (0.03x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
GRAL +33.96 pp
3M Horizon
GRAL +93.9 pp
6M Horizon
GRAL +114.63 pp
1Y Horizon
GRAL +66.7 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VCYT Revenue | GRAL Revenue | VCYT Op. Margin | GRAL Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $90M | N/A | -24.2% | N/A | VCYT |
| FY2019 | $120M | N/A | -12.6% | N/A | VCYT |
| FY2020 | $120M | N/A | -30.1% | N/A | VCYT |
| FY2021 | $220M | N/A | -37.3% | N/A | VCYT |
| FY2022 | $300M | N/A | -13.9% | N/A | VCYT |
| FY2023 | $360M | $90M | -23.8% | -1627.6% | VCYT |
| FY2024 | $450M | $130M | 3.6% | -1743.0% | VCYT |
| FY2025 | $520M | $150M | 11.2% | -382.0% | VCYT |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
VCYT
BREAKDOWN
Current IV
197.3%
IV Percentile
47th %ile
Put/Call OI Skew
0.01x (Call-Skewed)
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BEARISH
OBV Flow
DISTRIBUTION
Exact VCYT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
GRAL
BREAKDOWN
Current IV
93.0%
IV Percentile
53rd %ile
Put/Call OI Skew
0.81x (Call-Skewed)
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
DISTRIBUTION
Exact GRAL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
VCYT Moat Profile
Scale & Operating Efficiency Moat
Diagnostics & Research Operator
OpEx & R&D Reinvestment
59.2% of Rev ($344M)
90D Engineering Disclosures
0 Published
GRAL Moat Profile
Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ VCYT vs GRAL Key Questions & Quantitative Answers
As of Nov 16, 2026, GRAIL, Inc. (GRAL) captures the overall head-to-head institutional edge over Veracyte, Inc. (VCYT) on higher Unified Composite conviction (54.5/100 HOLD vs. 49.1/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples), while VCYT wins 5–1 across the 6-pillar growth and valuation breakdown. VCYT trades at $24.01 (15.3x Forward P/E, 15.0% operating margin) versus GRAL at $105.60 (1.1x Forward P/E, -332.0% operating margin). Growth vs. Quality Trade-Off: GRAL earns the overall head-to-head edge with a stronger Unified Composite Score (54.5/100 HOLD vs. VCYT 49.1/100 HOLD) and 3.09β · 99% Vol risk profile, whereas VCYT leads top-line expansion (+15.1% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: VCYT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 27.8); meanwhile GRAL is in a Breakdown options structure phase (RSI 37.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
VCYT leads the Growth & Scale pillar: VCYT posts +15.1% YoY revenue growth and +58.3% YoY earnings growth on $582M TTM revenue (74.2% gross margin, 15.0% operating margin), compared with GRAL at +3.7% YoY revenue growth and +0.0% YoY earnings growth on $167M TTM revenue (46.7% gross margin, -332.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), VCYT cumulative revenue shifted +477.8% while GRAL shifted +66.7%. In operating R&D and SG&A reinvestment, VCYT deploys 59.2% of Rev ($344M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GRAL.
GRAL screens cheaper on headline valuation multiples. VCYT trades at 15.3x Forward P/E, 15.8x Trailing P/E, N/M PEG, and 3.1x EV/Revenue (27.8% FCF margin), whereas GRAL trades at 1.1x Forward P/E, 1.1x Trailing P/E, N/M PEG, and 31.6x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VCYT (9.4% ROE) versus GRAL (-17.3% ROE) capital efficiency.
In options market volatility and institutional positioning, VCYT carries 197.3% implied volatility (47th %ile, Balanced (25th–60th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.01β · 199% Vol realized risk). By comparison, GRAL carries 93.0% implied volatility (53rd %ile, Balanced (25th–60th %ile)), a 0.81x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.09β · 99% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
GRAL vs VCYT · Reverse Pair
VCYT vs CDNA
· Sector Peer
VCYT vs TWST
· Sector Peer
VCYT vs TXG
· Sector Peer
GRAL vs RVMD
· Sector Peer
GRAL vs WGS
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem